Catalyst Wire Dossier Catalyst Wire Dossier

IBANDRONATE SODIUM

ibandronate sodium · Apotex Corp.
Drug timelines are a Plus or Pro feature.

35 regulatory and trial events tracked for IBANDRONATE SODIUM, covering 2012-03-19 to 2026-02-03. Get the full timeline:

Most recent: FDA Approved: IBANDRONATE SODIUM — Supplemental Application (Macleods Pharmaceuticals Limited)

See pricing